Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
Clinical trial NCT06675864 · RECRUITING
Trial details
- NCT number
- NCT06675864
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2030-06-14
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.